American journal of cardiovascular drugs : drugs, devices, and other interventions
Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future Directions.
Francesca Campanella, Francesco Barreca, Simona Giubilato, Giulia Alagna, Giovanni Taverna, Domenico Mario Giamundo, Ahmed Ibrahim, Pierre Sabouret, Francesco Amico, Giuseppe Andò
Published: 202610.1007/s40256-025-00787-0
Abstract
Despite major advances with direct oral anticoagulants (DOACs), the clinical challenge of minimizing bleeding without losing efficacy remains unresolved. Factor XI (FXI) plays a pivotal role in thrombosis with limited contribution to hemostasis, maki…
Preview only. Read the full abstract at the source